Encepur und fsme-immun
Die FSME-Impfstoffe beider Hersteller (FSME-IMMUN ® und ENCEPUR ®) werden als gleichwertig und austauschbar angesehen. In Untersuchungen hat sich . Currently, there are 4 widely used vaccines of assured quality: FSME-Immun and Encepur, manufactured in Austria and Germany respectively, and based on European strains of .
In Untersuchungen hat sich herausgestellt, dass im Bedarfsfall ein Wechsel zwischen den Impfstoffen ohne Einbuße der Wirksamkeit möglich ist.
1
Es gibt sie je in einer Version für Erwachsene und Kinder: Encepur® beziehungsweise Encepur® Kinder von Bavarian Nordic und FSME-Immun .
2
Zwei Impfstoffhersteller teilen sich den FSME-Markt in Deutschland – Bavarian Nordic mit Encepur® und Pfizer mit FSME-Immun.
3
Laut RKI können beide FSME-Impfstoffe (FSME-Immun und Encepur®) als gleichwertig und austauschbar angesehen werden. | Bild: IMAGO / Eibner.
4
Immunization offers the most effective protection. Currently, there are 4 widely used vaccines of assured quality: FSME-Immun and Encepur, manufactured in Austria and Germany respectively, and based on European strains of the virus; and TBE-Moscow and EnceVir, manufactured in the Russian Federation and based on Far-Eastern strains.
5
SME-F IMMUN / Tico Vac • mL with µg TBEV -EU for use as of ≥ 16years of age FSME-IMMUN Junior / Tico Vac Junior • mL with µg TBEV-EU for use in children and adolescents 1–15 years of age • US tradename BD T 3.
6
Ten VBIs had homologous vaccination series (6 FSME-IMMUN, 4 ENCEPUR), four had heterologous series, three lacked data. The median interval between last dose and onset was years (range 70 days.
7
A study from suggests that the FSME-Immun/Ticovac and Encepur are interchangeable for booster vaccination, but cautions against change during the primary immunization course. History. The first vaccine against TBE was prepared in in the brains of mice.
8
controlled, phase III clinical study compared the immunogenicity and safety of FSME-IMMUN® Junior and Encepur Children® in children aged years. With FSME-IMMUN® Junior, the seropositivity rates as determined by NT 28 days after the second vaccination were % in all three age groups (1–2, 3–6 and 7–11 years). The.
9
However, among children aged years, local reactions were significantly higher after the first (pEncepur Children than with FSME-IMMUN Junior, affecting half the children in the former group: % and % with FSME-IMMUN Junior vs. % and % for Encepur Children. fsme-impfung spätfolgen
10
FSME-Impfstoffe. Encepur 0,25 ml für Kinder. FSME -Adsorbat-Impfstoff (Virusimpfstoff, inaktiviert) FSME -IMMUN 0,5 ml Erwachsene.
11
The production processes of Encepur and FSME-IMMUN ® are similar with the only significant differences being in the final formulation. Both vaccines have been shown to . This single-blind, multi-center, randomized, controlled, phase III clinical study compared the immunogenicity and safety of the two paediatric TBE vaccines available in .